Vertiv Holdings Co (NYSE:VRT) Poised for Growth, Evercore Lifts Price Target and Reiterates “Outperform”
We recently compiled a list of the 15 AI News You Must Read Today. In this article, we are going to take a look at where ...
Investor's Business Daily on MSN44m
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug from China's LaNova Medicines.Please watch the video at Investors.com - ...